Sylvia Hahn

Title: Sylvia Hahn - Innovator in Transdermal Therapeutic Systems

Introduction

Sylvia Hahn is a notable inventor based in Bendorf, Germany. She has made significant contributions to the field of transdermal therapeutic systems, particularly with her innovative work involving the active substance 17-beta-estradiol. Her dedication to advancing medical technology has led to the development of a unique patent that addresses important therapeutic needs.

Latest Patents

Sylvia Hahn holds a patent for a transdermal therapeutic system designed for the release of 17-beta-estradiol. This invention features a laminated structure that includes a backing layer impermeable to moisture and active substances, along with one or more matrix layers. The system is characterized by the concentration of dissolved estradiol in the matrix layers, which is maintained between its saturation concentrations in both dry and moist conditions. This innovative approach enhances the effectiveness of the therapeutic system.

Career Highlights

Throughout her career, Sylvia has been associated with LTS Lohmann Therapie-Systeme GmbH, where she has played a crucial role in the development of advanced therapeutic systems. Her work has not only contributed to the company's success but has also had a positive impact on patient care and treatment options.

Collaborations

Sylvia Hahn has collaborated with esteemed colleagues, including Michael Horstmann and Reinhold Meconi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of therapeutic systems.

Conclusion

Sylvia Hahn's contributions to the field of transdermal therapeutic systems exemplify her commitment to innovation and improving healthcare solutions. Her patent for the transdermal release of 17-beta-estradiol showcases her expertise and dedication to advancing medical technology.